Broadwood Partners Comments on STAAR Surgical Shareholders' Rejection of the Company's Proposed Sale to Alcon
StockNews.AI • 2 days
Medium Materiality5/10
Information
Thanks Fellow Shareholders for Rejecting the Transaction Reiterates Enthusiasm for the Company's Standalone Prospects Looks Forward to Engaging with Board and Fellow Shareholders and Working Towards a Bright Future
Original sourceCorporate Developments
While the acquisition was significant, its rejection does not fundamentally alter ALC's business metrics, thus resulting in a moderate importance score.
FAQ
Why Neutral?
The rejection of the acquisition mitigates any immediate premium expected from ALC's bid, leading to stable valuations. However, ALC maintains a strong financial position independent of this transaction, suggesting no significant short-term impact on ALC’s stock price.
How important is it?
While the acquisition was significant, its rejection does not fundamentally alter ALC's business metrics, thus resulting in a moderate importance score.
Why Short Term?
The immediate impact revolves around the acquisition news, but as market sentiment stabilizes, any effect may diminish quickly given Alcon's operational strength.
Related Companies
Thanks Fellow Shareholders for Rejecting the Transaction
Reiterates Enthusiasm for the Company's Standalone Prospects
Looks Forward to Engaging with Board and Fellow Shareholders and Working Towards a Bright Future for STAAR
Broadwood Partners, L.P. and its affiliates ("Broadwood" or "we"), which together own 30.2% of the outstanding common stock of STAAR Surgical Company ("STAAR" or the "Company") (NASDAQ:STAA), commented on the results of the Special Meeting of Shareholders (the "Special Meeting") that was held earlier today in connection with the proposed acquisition of STAAR by Alcon Inc. ("Alcon") (NYSE:ALC). Based on preliminary results, shareholders voted decisively to reject the proposed transaction.
Neal C. Bradsher, Broadwood Founder and President, said:
"We thank our fellow shareholders for their attention during this process and for rejecting the proposed acquisition of STAAR by Alcon at today's Special Meeting. We appreciate that so many shareholders recognize the value of STAAR and share our enthusiasm for the Company's bright future.
It is now time to focus on the road ahead. With its leading technology, strong financial position, privileged position in large markets, and clear path to growth and profit margin expansion in both the near term and the long term, STAAR's future is bright. As STAAR's largest shareholder, we are confident in the Company's standalone prospects and committed to helping STAAR realize its abundant potential for the benefit of all shareholders.
To that end, we are ready and willing to work collaboratively with the Board and our fellow shareholders to implement the necessary changes to enable effective oversight and execution on STAAR's opportunity to become a highly profitable and scaled enterprise.
STAAR now has a renewed opportunity to truly shine."
About Broadwood
Broadwood Partners, L.P. is managed by Broadwood Capital, Inc. Broadwood Capital is a private investment firm based in New York City. Neal Bradsher is the President of Broadwood Capital.
View source version on businesswire.com: https://www.businesswire.com/news/home/20260106480307/en/
Investor Contacts
John Ferguson / Joseph Mills
Saratoga Proxy Consulting LLC
jferguson@saratogaproxy.com
jmills@saratogaproxy.com
(212) 257-1311
(888) 368-0379
Media Contacts
Scott Deveau / Jeremy Jacobs
August Strategic Communications
Broadwood@AugustCo.com
(323) 892-5562